Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
siremadlin (HDM201)
i
Other names:
HDM201, HDM 201, HDM-201, NVP-HDM201, NVP-HDM-201, NVP-HDM 201
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Novartis
Drug class:
MDM2 inhibitor
Related drugs:
‹
KRT-232 (18)
RAIN-32 (13)
RG7388 (10)
APG-115 (9)
CGM097 (4)
ALRN-6924 (3)
MK-8242 (2)
Nutlin-3 (1)
ASTX295 (0)
DS-5272 (0)
MI-773 (0)
RG7112 (0)
RG7775 (0)
JNJ-26854165 (0)
KRT-232 (18)
RAIN-32 (13)
RG7388 (10)
APG-115 (9)
CGM097 (4)
ALRN-6924 (3)
MK-8242 (2)
Nutlin-3 (1)
ASTX295 (0)
DS-5272 (0)
MI-773 (0)
RG7112 (0)
RG7775 (0)
JNJ-26854165 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
TP53 wild-type
Acute Myelogenous Leukemia
TP53 wild-type
Acute Myelogenous Leukemia
HDM201
Sensitive: C3 – Early Trials
HDM201
Sensitive
:
C3
HDM201
Sensitive: C3 – Early Trials
HDM201
Sensitive
:
C3
TP53 wild-type
Solid Tumor
TP53 wild-type
Solid Tumor
HDM201
Sensitive: C3 – Early Trials
HDM201
Sensitive
:
C3
HDM201
Sensitive: C3 – Early Trials
HDM201
Sensitive
:
C3
TP53 wild-type
Liposarcoma
TP53 wild-type
Liposarcoma
HDM201
Sensitive: C3 – Early Trials
HDM201
Sensitive
:
C3
HDM201
Sensitive: C3 – Early Trials
HDM201
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login